Cargando…
Efficacy of cabergoline add-on therapy in patients with acromegaly resistance to somatostatin analogs treatment and the review of literature
OBJECTIVE: It is reported that adding cabergoline to somatostatin analog (SSA) normalizes IGF-1 levels approximately in one-third of patients with acromegaly. We investigated the effect of combination therapy and potential predictors of response in patients with acromegaly who do not respond to SSA...
Autores principales: | Kizilgul, Muhammed, Duger, Hakan, Nasiroglu, Narin Imga, Sencar, Erkam, Hepsen, Sema, Akhanli, Pinar, Berker, Dilek, Cakal, Erman, Bostan, Hayri, Ucan, Bekir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832853/ https://www.ncbi.nlm.nih.gov/pubmed/35612842 http://dx.doi.org/10.20945/2359-3997000000481 |
Ejemplares similares
-
The role of elastography in the assessment of thyroid nodules in acromegaly
por: DÜĞER, Hakan, et al.
Publicado: (2022) -
Fatty acid-binding protein-4 as a biomarker predicting acromegaly-associated diabetes mellitus
por: HEPŞEN, Sema, et al.
Publicado: (2021) -
The value of routine measurement of serum calcitonin on insufficient, indeterminate, and suspicious thyroid nodule cytology
por: Sencar, Muhammed Erkam, et al.
Publicado: (2022) -
Evaluation of the diagnostic features and clinical course of COVID-19 vaccine–associated subacute thyroiditis
por: Bostan, Hayri, et al.
Publicado: (2022) -
The contribution of ultrasonographic findings to the prognosis of subacute thyroiditis
por: Sencar, Muhammed Erkam, et al.
Publicado: (2020)